CDK2 inhibitor 73
CAS No. 2079895-42-2
CDK2 inhibitor 73( CDK2-IN-73 | CDK2 IN 73 | CDK2IN73 | CDK2 inhibitor 73 )
Catalog No. M13236 CAS No. 2079895-42-2
A potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 205 | Get Quote |
|
10MG | 335 | Get Quote |
|
25MG | 566 | Get Quote |
|
50MG | 806 | Get Quote |
|
100MG | 1098 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDK2 inhibitor 73
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
DescriptionA potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
In Vitro——
-
In Vivo——
-
SynonymsCDK2-IN-73 | CDK2 IN 73 | CDK2IN73 | CDK2 inhibitor 73
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2079895-42-2
-
Formula Weight442.497
-
Molecular FormulaC23H18N6O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20.83 mg/mL (47.07 mM)
-
SMILESO=S(C1=CC=C(NC2=NC(C3=CC(C4=CC=CC=C4)=CC=C3)=C5N=CNC5=N2)C=C1)(N)=O
-
Chemical Name4-((6-([1,1'-biphenyl]-3-yl)-9H-purin-2-yl)amino) benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Coxon CR, et al. J Med Chem. 2017 Mar 9;60(5):1746-1767.
molnova catalog
related products
-
IIIM-290
IIIM-290 is a potent, orally active cyclin-dependent kinase (CDK) inhiitor with IC50 of 1.9 and 16 nM for Cdk-9/T1 and Cdk-2/A, respectively.
-
Olomoucine
A potent, ATP-competetive CDKs inhibitor with IC50 of 7, 7, 7, 3 uM for Cdc2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk/p35 kinase; also inhibits ERK1/MAP kinase (IC50=25 uM).
-
BAY-958
BAY-958 (BAY958, LDC526)?is a potent, selective PTEFb/CDK9 inhibitor with IC50 of 5 nM against CDK9/CyclinT1.